About the Cancer Center
Our goal is an increased translational focus on tailoring new cancer therapies to individual patients, thus enabling personalized medicine.
Cancer, the second most common cause of death in the U.S., will account for an estimated 1.66 million newly diagnosed cases and 585,720 deaths nationwide in 2014. The Sanford-Burnham Cancer Center, one of only seven National Cancer Institute (NCI)-designated basic research cancer centers in the country, is leading the effort to eradicate this disease. To that end, it is striving to make personalized cancer medicine a reality through its exceptional translational research.
What are the goals and activities of the Center?
Founded in 1976 as the La Jolla Cancer Research Foundation, the Cancer Center first received its NCI-designation in 1981. The Center conducts paradigm-shifting, collaborative multidisciplinary basic research into the causes, prevention, and treatment of cancer, leading to new therapies that overcome cancer as a cause of human suffering and disease. Additionally, the Center is committed to educating and training the next generation of cancer scientists.
An area of long-standing and exceptional strength of the Cancer Center is basic science discovery into novel cancer gene targets and their mechanisms. The Center is built around three programs that reflect the cancer continuum of initiation, maintenance, survival, death, and metastasis as well as the contributions of the tumor microenvironment. Investigators advance their discoveries through small-molecule-based drug discovery, an area where we have significant capabilities, into early preclinical therapeutic development.
The Cancer Center is poised to achieve its vision by leveraging its scientific strengths through collaborations with academic and private sector investigators locally, nationally and internationally.